Recruiting NA Anorexia Nervosa

New treatment option for Anorexia Nervosa

Official title Adapted Physical Activity in the Treatment of Anorexia:

ClinicalTrials.gov ID: NCT05477537

What this study is testing

What it's testing
People with anorexia nervosa are known to engage in significant physical activity or sports. This practice is problematic because of the state of malnutrition, its interference with re-nutrition and the somatic and nutritional complications that the effect of physical activity can cause in these people.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 12 to 40

You may be able to join if

  • Anorexia nervosa patients (DSM 5 criteria),
  • over or equal to 12 years old,
  • Treated in the specialised eating disorder centres involved in the study either in the day hospital program or in the inpatient program,
  • Understanding, reading and writing French,
  • Benefiting from social cover

You likely can't join if

  • Somatic instability needing intensive medical care or monitoring (intensity is adapted in each session to each patient) or psychiatric emergency...
  • Somatic complication forbidding any physical activity,
  • Absence social cover,
  • Patients in an emergency situation, incapable of giving their consent or adults under guardianship or curatorship,
  • Pregnant or breastfeeding women (declarative: question asked to the patient during inclusion),
  • Refusal to participate.
See the full eligibility criteria
Who can join
  • Anorexia nervosa patients (DSM 5 criteria),
  • over or equal to 12 years old,
  • Treated in the specialised eating disorder centres involved in the study either in the day hospital program or in the inpatient program,
  • Understanding, reading and writing French,
  • Benefiting from social cover
  • Have read the information notice and have consented to participate in the study by signing a written consent
What rules you out
  • Somatic instability needing intensive medical care or monitoring (intensity is adapted in each session to each patient) or psychiatric emergency (suicidal risk and/or acute psychiatric symptomatology),
  • Somatic complication forbidding any physical activity,
  • Absence social cover,
  • Patients in an emergency situation, incapable of giving their consent or adults under guardianship or curatorship,
  • Pregnant or breastfeeding women (declarative: question asked to the patient during inclusion),
  • Refusal to participate.

The study team makes the final eligibility decision.

Where it's taking place

  • Lille, France
  • Lyon, France
  • Montpellier, France
  • Nantes, France
  • Paris, France
  • Saint-Etienne, France

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 12 years to 40 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lille, France; Lyon, France; Montpellier, France; Nantes, France; Paris, France; Saint-Etienne, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.